Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neda Hekmati

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neuro-Oncology|December 17, 2021
Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenograftsElin Almstedt, Emil Rosén, Marleen Gloger, et al.
Molecular Oncology|October 17, 2025
Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensityLiqun He, Chiara Testini, Neda Hekmati, et al.
Scientific Reports|July 1, 2026
Immune cell landscape and metabolic gene activity distinguish triple negative from luminal A-like ductal carcinoma in situJens Henrik Norum, Hossein Schandiz, Torill Sauer, et al.
Acta Neuropathologica Communications|November 11, 2021
Annotation of pituitary neuroendocrine tumors with genome-wide expression analysisAbdellah Tebani, Jelena Jotanovic, Neda Hekmati, et al.
Journal of the Endocrine Society|March 20, 2024
Transcriptome Analysis Reveals Distinct Patterns Between the Invasive and Noninvasive Pituitary Neuroendocrine TumorsJelena Jotanovic, Abdellah Tebani, Neda Hekmati, et al.
Cell Communication and Signaling : CCS|January 16, 2026
In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLCAmanda Lindberg, Louise Hellberg, Anaïs Grandon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 1, 2025
In Situ Detection of Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Interactions as a Functional Predictor for Response to Immune Checkpoint Inhibition in NSCLCAmanda Lindberg, Lars Muhl, Hui Yu, et al.
Nature Communications|January 5, 2020
Integrative discovery of treatments for high-risk neuroblastomaElin Almstedt, Ramy Elgendy, Neda Hekmati, et al.
Nature Communications|September 26, 2025
An injury-associated lobular microniche is associated with the classical tumor cell phenotype in pancreatic cancerSara Söderqvist, Annika Viljamaa, Natalie Geyer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neuro-Oncology|December 17, 2021
Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenograftsElin Almstedt, Emil Rosén, Marleen Gloger, et al.
Molecular Oncology|October 17, 2025
Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensityLiqun He, Chiara Testini, Neda Hekmati, et al.
Scientific Reports|July 1, 2026
Immune cell landscape and metabolic gene activity distinguish triple negative from luminal A-like ductal carcinoma in situJens Henrik Norum, Hossein Schandiz, Torill Sauer, et al.
Acta Neuropathologica Communications|November 11, 2021
Annotation of pituitary neuroendocrine tumors with genome-wide expression analysisAbdellah Tebani, Jelena Jotanovic, Neda Hekmati, et al.
Journal of the Endocrine Society|March 20, 2024
Transcriptome Analysis Reveals Distinct Patterns Between the Invasive and Noninvasive Pituitary Neuroendocrine TumorsJelena Jotanovic, Abdellah Tebani, Neda Hekmati, et al.
Cell Communication and Signaling : CCS|January 16, 2026
In situ mapping of activated PDGFRβ defines a prognostic discrepancy between histological subtypes of NSCLCAmanda Lindberg, Louise Hellberg, Anaïs Grandon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 1, 2025
In Situ Detection of Programmed Cell Death Protein 1 and Programmed Death Ligand 1 Interactions as a Functional Predictor for Response to Immune Checkpoint Inhibition in NSCLCAmanda Lindberg, Lars Muhl, Hui Yu, et al.
Nature Communications|January 5, 2020
Integrative discovery of treatments for high-risk neuroblastomaElin Almstedt, Ramy Elgendy, Neda Hekmati, et al.
Nature Communications|September 26, 2025
An injury-associated lobular microniche is associated with the classical tumor cell phenotype in pancreatic cancerSara Söderqvist, Annika Viljamaa, Natalie Geyer, et al.
Pageof 1